[1] LANDSTEINER K. Agglutination phenomena of normal human blood[J]. Wiener Klinische Wochenschrift, 2001, 113(20-21): 768-769.[2] WATKINS W M. Biochemistry and genetics of the ABO, Lewis, and P blood group systems[J]. Advances in Human Genetics, 1980(10): 1-136, 379-385.[3] 章扬培,季守平,杨军.血型转变[J].中国实验血液学杂志,1998, 6(2): 91-97.[4] LIU Q P, SULZENBACHER G, YUAN H, et al. Bacterial glycosidases for the production of universal red blood cells[J]. Nature Biotechnology, 2007, 25(4): 454-464.[5] BAEHR R V. Biotechnology of blood[J]. Biotechnology, 1991, 19: 1-463.[6] GOLDSTEIN J, SIVIGLIA G, HURST R, et al. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals[J]. Science, 1982, 215(4529): 168-170.[7] KRUSKALL M S, AUBUCHON J P, ANTHONY K Y, et al. Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O[J]. Transfusion, 2000, 40(11): 1290-1298.[8] ZHU A, GOLDSTEIN J. Cloning and functional expression of a cDNA encoding coffee bean alpha-galactosidase[J]. Gene, 1994, 140(2): 227-231.[9] OLSSON M L, CLAUSEN H. Modifying the red cell surface: towards an ABO-universal blood supply[J]. British Journal of Haematology, 2008, 140(1): 3-12.[10] DANIELS G, WITHERS S G. Towards universal red blood cells[J]. Nature Biotechnology, 2007, 25(4): 427-428.[11] LENNY L L, GOLDSTEIN J. The production of group O cells[J]. Biotechnology, 1991, 19: 75-100.[12] LAVECCHIO J A, DUNNE A D, EDGE A S. Enzymatic removal of alpha-galactosyl epitopes from porcine endothelial cells diminishes the cytotoxic effect of natural antibodies[J]. Transplantation, 1995, 60(8): 841-847.[13] 杨军,宫锋,季守平.B→O血型转变工具酶α-半乳糖苷酶cDNA克隆及表达[J]. 中国生物化学与分子生物学报,2000, 16(4): 438-442.[14] STEMMER W P. Rapid evolution of a protein in vitro by DNA shuffling[J]. Nature, 1994, 370(6488): 389-391. |